The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients

被引：6
|
作者：
El Desoky, Ehab S. [1 ]
Abdelhafez, Alaa T. [1 ]
Cusato, Jessica [2 ]
Kamel, Sherif I. [3 ]
Hussein, Abeer M. R. [1 ]
De Nicolo, Amedeo [2 ]
Di Perri, Giovanni [2 ]
D'Avolio, Antonio [2 ]
机构：
[1] Assiut Univ, Dept Pharmacol, Fac Med, Assiut, Egypt
[2] Univ Turin, Amedeo di Savoia Hosp, Infect Dis Unit, Dept Med Sci, Turin, Italy
[3] Assiut Univ, Dept Trop Med & Gastroenterol, Fac Med, Assiut, Egypt
来源：
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2017年 / 44卷 / 09期
关键词：
anaemia; ITPA; pharmacogenetics; ribavirin; SLC28A3; SLC29A1; HCV PATIENTS; INFECTION; VARIANTS; SERUM;
D O I：
10.1111/1440-1681.12786
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Few data are available concerning the roles of polymorphisms of inosine triphosphatase (ITPA) gene and ribavirin (RBV) transporter genes in the prediction of RBV-induced anaemia among Egyptians with chronic hepatitis C (CHC). Genotyping of three ITPA gene variants and two variants of RBV transporter genes has been performed in 123 patients under pegylated interferon-/ribavirin treatment. The baseline haemoglobin and ITPA rs1127354 CA/AA have been found as predictors of anaemia at 4, 8 and 12weeks of RBV therapy. In addition, ITPA rs7270101 AC/CC and age predicted anaemia after 12weeks of therapy. In conclusion, the ITPA variant rs1127354C>A significantly predict RBV-induced anaemia during the first 3months of treatment and it is recommended to be assessed before RBV administration.
引用
收藏
页码：965 / 968
页数：4
相关论文
共 50 条
  • [21] PREDICTION MODEL OF RIBAVIRIN-INDUCED ANEMIA INCORPORATING ITPA GENOTYPE COULD IDENTIFY CHRONIC HEPATITIS C PATIENTS AT HIGH RISK OF RELAPSE AMONG VIROLOGICAL RESPONDERS TO PEGYLATED-INTERFERON AND RIBAVIRIN
    Kurosaki, Masayuki
    Itakura, Jun
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Tanaka, Yasuhito
    Mizokami, Masashi
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Izumi, Namiki
    HEPATOLOGY, 2011, 54 : 823A - 823A
  • [22] Pharmacogenetics of ribavirin-induced anemia in hepatitis C
    Ampuero, Javier
    Romero-Gomez, Manuel
    PHARMACOGENOMICS, 2016, 17 (14) : 1587 - 1594
  • [23] Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection
    Abel, Shawna
    Aminkeng, Folefac
    Kowalec, Kaarina
    Drogemoller, Britt
    Wright, Galen
    Bader, Rachel
    Stortz, Jessica
    Yoshida, Eric
    Lee, Sam
    Al-Judaibi, Bandar
    Kim, Richard
    Tam, Edward
    Ramji, Alnoor
    Ross, Colin
    Carleton, Bruce
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 167 - 167
  • [24] Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment
    Ampuero, Javier
    Antonio Del Campo, Jose
    Rojas, Lourdes
    Luis Calleja, Jose
    Cabezas, Joaquin
    Lens, Sabela
    Crespo, Javier
    Forns, Xavier
    Andrade, Raul J.
    Fernandez, Inmaculada
    Buti, Maria
    Millan, Raquel
    Romero-Gomez, Manuel
    JOURNAL OF CLINICAL VIROLOGY, 2015, 68 : 56 - 60
  • [25] Association of ITPA Gene Polymorphisms and the Risk of Ribavirin-Induced Anemia in HIV/Hepatitis C Virus (HCV)-Coinfected Patients Receiving HCV Combination Therapy
    Domingo, Pere
    Guardiola, Josep M.
    Salazar, Juliana
    Torres, Ferran
    Gracia Mateo, M.
    Pacho, Cristina
    del Mar Gutierrez, M.
    Lamarca, Karuna
    Fontanet, Angels
    Martin, Jordi
    Munoz, Jessica
    Vidal, Francesc
    Baiget, Montserrat
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2987 - 2993
  • [26] Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C
    Delvaux, Nathalia
    da Costa, Vanessa Duarte
    da Costa, Maristella Matos
    Villar, Livia Melo
    Moraes Coelho, Henrique Sergio
    Cathala Esberard, Eliane Bordalo
    Flores, Priscila Pollo
    Brandao-Mello, Carlos Eduardo
    Villela-Nogueira, Cristiane Alves
    de Almeida, Adilson Jose
    Lampe, Elisabeth
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2015, 110 (05): : 636 - 643
  • [27] ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients
    Abdelhafez, A.
    Cusato, J.
    Hussein, A.
    Kamel, S.
    De Nicolo', A.
    Di Perri, G.
    D'Avolio, A.
    El Desoky, E.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 27 - 28
  • [28] Ribavirin-induced anemia: Incidence and impact to treatment response of chronic hepatitis C
    Leerapun, Apinya
    Soontornpun, Atiwat
    Pisespongsa, Pises
    Chitapanarux, Taned
    Kijdamrongthum, Phuripong
    Thongsawat, Satawat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 267 - 267
  • [29] Ribavirin-Induced Anemia is Affected by Renal Function in Elderly Chronic Hepatitis C(CHC)Patients
    Spinzi, Giancarlo
    Borroni, Gianmario
    Andreoletti, Marco
    Bortoli, Aurora
    Casiraghi, Mariaantonietta
    Cazzaniga, Massimo
    Ceriani, Roberto
    Guerzoni, Patrizia
    Pich, Maria Gioia
    Prada, Alberto
    Omazzi, Barbara
    Terreni, Natalia M.
    GASTROENTEROLOGY, 2011, 140 (05) : S949 - S949
  • [30] A formula to estimate the optimal dosage of ribavirin for the treatment of chronic hepatitis C: influence of ITPA polymorphisms
    Krishnan, Sheeja M.
    Dixit, Narendra M.
    ANTIVIRAL THERAPY, 2012, 17 (08) : 1581 - 1592
12345